Related Experiment Video
Updated: Jan 8, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Variants in AKR1D1 and Infant Mortality: Should Bile Acid Screening be a Routine Part of Newborn Screening?
Jade Hudson1, Stephanie Hyunh1, Bojana Rakic2
1Department of Medical Genetics and Provincial Medical Genetics Program, University of British Columbia and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada.
Congenital Bile Acid Synthesis defect type 2 (CBAS2), caused by AKR1D1 variants, disrupts bile acid production. Early diagnosis and intervention are crucial to prevent severe outcomes like infant death.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Biallelic pathogenic variants in AKR1D1 lead to Δ4-3-oxosteroid 5β-reductase deficiency.
- This deficiency disrupts bile acid synthesis, causing Congenital Bile Acid Synthesis defect type 2 (CBAS2).
- CBAS2 manifests in infancy with cholestasis, coagulopathy, and failure to thrive.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Pedigree Analysis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inborn Errors of Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...